Choreo LLC Grows Stock Position in HealthEquity, Inc. (NASDAQ:HQY)

Choreo LLC boosted its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 7.2% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 22,879 shares of the company’s stock after buying an additional 1,533 shares during the quarter. Choreo LLC’s holdings in HealthEquity were worth $2,204,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. GDS Wealth Management raised its holdings in HealthEquity by 43.6% during the 4th quarter. GDS Wealth Management now owns 41,131 shares of the company’s stock valued at $3,947,000 after buying an additional 12,493 shares during the period. Greenleaf Trust purchased a new stake in HealthEquity during the 4th quarter valued at $214,000. KBC Group NV raised its holdings in HealthEquity by 56.7% during the 4th quarter. KBC Group NV now owns 3,860 shares of the company’s stock valued at $370,000 after buying an additional 1,397 shares during the period. Curated Wealth Partners LLC purchased a new stake in HealthEquity during the 4th quarter valued at $242,000. Finally, Exchange Traded Concepts LLC raised its holdings in HealthEquity by 2.6% during the 4th quarter. Exchange Traded Concepts LLC now owns 9,813 shares of the company’s stock valued at $942,000 after buying an additional 245 shares during the period. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Price Performance

HQY opened at $112.07 on Friday. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $113.22. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The business’s fifty day simple moving average is $100.77 and its 200-day simple moving average is $89.34. The company has a market capitalization of $9.71 billion, a price-to-earnings ratio of 102.82, a PEG ratio of 1.94 and a beta of 0.55.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period in the prior year, the company posted $0.40 EPS. On average, equities research analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Insider Activity at HealthEquity

In other HealthEquity news, Director Stuart B. Parker sold 25,000 shares of the stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the sale, the director now directly owns 19,061 shares in the company, valued at approximately $1,843,579.92. This trade represents a 56.74 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Robert W. Selander sold 8,250 shares of the stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $101.56, for a total value of $837,870.00. Following the completion of the sale, the director now owns 66,469 shares of the company’s stock, valued at approximately $6,750,591.64. This trade represents a 11.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.20% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

HQY has been the topic of several research analyst reports. Bank of America upped their price objective on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. JMP Securities upped their price objective on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research report on Tuesday, December 10th. Barrington Research upped their price objective on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research report on Monday, December 2nd. Royal Bank of Canada upped their price objective on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research report on Tuesday, December 10th. Finally, Mizuho initiated coverage on HealthEquity in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price objective on the stock. One research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $110.71.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.